Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Patrys GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Oncology, Infectious Diseases, Antibody, Drug DevelopmentPatrys – the natural human antibody based company. Patrys Limited (ASX:PAB) is an Australian public company committed to the development ofnovel treatments for cancer and other diseases, including the commercialisationof a unique natural human antibody based therapies for the treatmentof lung, pancreatic, gastric and colon cancers.The company has the world-wide and exclusive rights to technologies thathave been developed over 25 collective years of research and developmentand which uniquely allow for the capture, development and production ofnatural human antibodies for potential therapeutic applications. The technologies,and resulting deep product pipeline, have achieved positive resultsin animal studies in the treatment of human lung, pancreatic, gastric andcolon cancers.Patrys also currently benefits from the prior establishment of drug developmentcollaborations with three large pharmaceutical companies.In addition to its internal drug development projects and existing collaborations,the company has also acquired a substantial preferred equity holdingin Acceptys, Inc., an American company developing the platform naturalhuman antibody technology for the treatment of infectious diseases, includingHepatitis C, Hepatitis B, Pneumonia and Staph A.Patrys’ commercial strategy is to blend the internal development of leadproduct candidates while simultaneously benefiting from partnerships andcollaborations aimed at developing additional product candidates from thecompany’s deep product pipeline.Contact:Dr. Frank HenselFriedrich-Bergius-Ring 15D-97076 WürzburgPhone: +49 (0) 931 230795-0Fax: +49 (0) 931 230795-19E-Mail: info@patrys.comInternet: www.patrys.comPfizer Manufacturing Deutschland GmbHPHARMA & CHEMICAL INDUSTRYKeywords: Pain, Infectious Diseases, CNS, Cardiovascular Diseases, AutomationPfizer is a leading pharmaceutical company with headquarters in the USwhich develops, produces and distributes medicines and vaccines in differenttherapeutic fields. The product portfolio of the Pfizer Illertissen manufacturingsite is specialized in solid dosage forms sold globally. We stand fora high degree of automation, system integration and innovation with anexcellent supply performance. We provide innovative concepts and servicesin Containment Manufacturing and Wallet Packaging with a proven highquality and high service level at competitive costs. The unique expertise isproven by renowned awards achieved: Overall „Facility of the Year Award“from „International Society for Pharmaceutical Engineering“ (ISPE) in 2008for the fully automated containment manufacturing facility and „HealthcareCompliance Packaging Council (HCPC)-Columbus Award 2011“ for innovativecompliance packaging solutions realized with wallet cards.Contact:Dr. Peter RemigerHeinrich-Mack-Str. 35D-89257 IllertissenPhone: +49 (0) 7303 12-0Fax: +49 (0) 7303 12-387E-Mail: peter.remiger@pfizer.comInternet: www.pfizer.com99